The demand for high-quality biotherapeutics has never been greater. Higher-throughput protein expression, production and purification as well as more flexible expression systems and techniques are necessary to meet the demands for both biotherapeutic research and manufacturing pipelines. Throughout the week, the Biotherapeutic Expression & Production pipeline explores the newest data, innovations and strategies to make the expression of therapeutic proteins more efficient, effective and trouble-free.
Josh LaBaer, MD, PhD, Executive Director, Biodesign Institute, Arizona State University
Phillip Berman, PhD, Distinguished Research Professor, Biomolecular Engineering, University of California, Santa Cruz
John K. Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.